Delcath Systems Inc (DCTH)

[ash111]

DCTH only 425k shares offering, O/S still under 2M.W/ALMOST $40M IN CASH+RESTRICTED(10q),WAY UNDERVALUED.they actually don't need more cash, i smell a deal here. btw.i'm buying at those retail prices. Cap is only 3m now and after 425k shares. will be around 5m.

Delcath receives new FDA approval back in 2015 for "a type of liver cancer that affects bile ducts". it seems(DCTH known as confidentiality Co.) they did some major steps forward since then( beside closed $35 Million Funding Round back in June 2016,"One of the targets is in the Phase 2 and Phase 3 study of its Melphalan/HDS").

http://poststar.com/business/local/delcath-receives-new-fda-approval/article_0d206ce0-cfe0-5fa2-97cc-d7c911d1848d.html

recently mentioned as a major key player for Bile Duct Cancer,among big name companies : http://finance.yahoo.com/news/world-bile-duct-cancer-cholangiocarcinoma-150500717.html

Many events http://delcath.com/reuters-events-roll/